Retour aux projets

18391.1 PFLS-LS

3-Dimensional Microtissues for Highly Predictive Drug Evaluation

Résumé

3-Dimensional Microtissues for Highly Predictive Drug Evaluation

Textes supplémentaires

Abstract

Failure rates in drug development are unsustainably high and are most often attributed to poor performance of|a lead compound regarding safety and/or efficacy. Improving the predictive power of preclinical stage in vitro|tests for new drug safety and efficacy is key to reducing attrition. CellSpring¿s 3D Bloom microtissue platform|has shown promise for achieving these goals. This CTI project will enable the development and validation of|3D microtissue models for preclinical drug safety, preclinical efficacy testing for novel chemotherapeutics, and|automated handling for high throughput applications.

Participants

Chris Millan

Wirtschaftspartner

chris.millan@cellspring.co

CellSpring AG Chris Millan HPL D 16.1 / Otto-Stern-Weg 7 8093 Zürich ETH-Hönggerberg ZH CH

Marcy Zenobi-Wong

Kontaktperson

marcy.zenobi@hest.ethz.ch

ETH Zürich Marcy Zenobi-Wong Otto-Stern-weg 7 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-12-31
Date de fin
2017-12-31
Coûts totaux approuvés
CHF 344679.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%